Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of IGMS will decline by -2.62% over the next 2 Weeks and hit $1.24 by Friday, August 29, 2025. In that time frame, IGMS's share price is expected to range between $1.18 and $1.30.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 29, 2025 | 1.18 | 1.24 | 1.29 |
| Aug 28, 2025 | 1.21 | 1.27 | 1.32 |
| Aug 27, 2025 | 1.20 | 1.26 | 1.32 |
| Aug 26, 2025 | 1.21 | 1.27 | 1.33 |
| Aug 25, 2025 | 1.19 | 1.26 | 1.32 |
| Aug 22, 2025 | 1.18 | 1.24 | 1.31 |
| Aug 21, 2025 | 1.22 | 1.27 | 1.34 |
| Aug 20, 2025 | 1.21 | 1.27 | 1.33 |
| Aug 19, 2025 | 1.22 | 1.28 | 1.33 |
| Aug 18, 2025 | 1.20 | 1.26 | 1.32 |
IGMS shares remained flat 0 in Thursday, August 14, 2025's trading session, starting and closing at a previous close of $1.27 to move at $1.27. The stock demonstrated notable intraday movement (see IGMS's key stats for a full breakdown), fluctuating between $1.27 and $1.27, a 0 trading range. While recent weeks have seen some volatility, IGMS has managed to secure a -3.05% drop over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 0 shares changing hands, 1.59M fewer than the previous session. This amounted to $0.00 in total market activity.
Will IGMS Continue Its Upward Trend?
According to analyst ratings and projections for IGMS, IGM Biosciences, Inc. shares are anticipated to increase by +1.92%, potentially reaching $1.29 per share by August 29, 2025. Short-term technical indicators currently suggest a neutral sentiment for IGMS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 9 positive trading days within the past 30 sessions. Based on the IGMS stock forecast, now is a good time to buy IGMS stock because its current trading price is +2.69% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on IGMS covering social and institutional perspectives.
IGMS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into IGMS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 45.14% to 48.88%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 42.27%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.53%, maintains a neutral outlook for the long term. Insights into IGMS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
IGM Biosciences, Inc. Monthly Forecast 2025–2026
October 2025
According to our latest forecast models, IGM Biosciences, Inc. (IGMS) is positioned to show a strong performance in October 2025. The price is predicted to move between $0.00 and $0.48, settling at an average of $0.00. This could translate to a -100.00% loss.
November 2025
Based on current market signals, IGM Biosciences, Inc. is projected to trend november 2025. We forecast a trading range from $0.00 to $0.51, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
December 2025
Our predictive algorithms indicate IGM Biosciences, Inc. stock may see a shift in December 2025. The expected range spans $0.00–$0.52, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
January 2026
Analyzing established trends, IGM Biosciences, Inc. looks set to move in January 2026. Projections place the stock between $0.00 and $0.50, averaging around $0.00. This suggests a -100.00% loss from current levels.
February 2026
Market indicators suggest IGM Biosciences, Inc. could experience notable changes during February 2026. Prices could fluctuate within $0.00 to $0.54, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
March 2026
Forecasting for March 2026, models estimate that IGM Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.51, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
April 2026
According to our latest forecast models, IGM Biosciences, Inc. (IGMS) is positioned to show a strong performance in April 2026. The price is predicted to move between $0.00 and $0.52, settling at an average of $0.00. This could translate to a -100.00% loss.
May 2026
Based on current market signals, IGM Biosciences, Inc. is projected to trend may 2026. We forecast a trading range from $0.00 to $0.51, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
June 2026
Our predictive algorithms indicate IGM Biosciences, Inc. stock may see a shift in June 2026. The expected range spans $0.00–$0.55, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
July 2026
Analyzing established trends, IGM Biosciences, Inc. looks set to move in July 2026. Projections place the stock between $0.00 and $0.52, averaging around $0.00. This suggests a -100.00% loss from current levels.
August 2026
Market indicators suggest IGM Biosciences, Inc. could experience notable changes during August 2026. Prices could fluctuate within $0.00 to $0.51, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
IGMS's history of dividends and stock splits also plays a role in long-term investor confidence.